Hemodynamic Effects of Medetomidine-Midazolam-Butorphanol and Medetomidine-Midazolam-Buprenorphine Combinations and Reversibility by Atipamezole in Dogs
Pypendop, B.; Serteyn, Didier; Verstegen, J.
1996 • In American Journal of Veterinary Research, 57 (5), p. 724-30
[en] OBJECTIVE--To characterize the hemodynamic effects of medetomidine (1 mg/m2 of body surface area; dosage, 39 to 46 micrograms/kg of body weight, IM) and midazolam (1 mg/kg of body weight, i.v.) combined with butorphanol (0.1 mg/kg, i.v.), buprenorphine (10 micrograms/kg, i.v.) or saline solution. Reversibility of these effects by atipamezole (2.5 mg/m2; dosage, 97.5 to 115 micrograms/kg, IM) was evaluated. DESIGN--2 treated groups and 1 control group, without repetition. ANIMALS--15 clinically normal dogs (3 groups of 5). PROCEDURE--Medetomidine was administered at time 0; midazolam and butorphanol, buprenorphine, or saline solution at time 20; and atipamezole at time 60. Heart rate, systemic and pulmonary arterial pressures, central venous pressure, body temperature, cardiac output, and arterial and mixed venous blood gas tensions and pH were measured. Cardiac index, stroke index, systemic and pulmonary vascular resistances, and left and right stroke work indexes were calculated. RESULTS--Body temperature, heart rate, cardiac index, and stroke index were significantly decrease below baseline values in some groups. Central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance were significantly increased above baseline in all groups. Arterial and venous PO2 and pH decreased in all groups and PCO2 increased, but these changes were more pronounced when buprenorphine was administered. Arterial pressure decreased after atipamezole administration. CONCLUSION--The combinations seemed to result in cardiorespiratory depressant effects of similar importance and most of these effects, which are related to medetomidine, were reversed by atipamezole.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Pypendop, B.
Serteyn, Didier ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Verstegen, J.
Language :
English
Title :
Hemodynamic Effects of Medetomidine-Midazolam-Butorphanol and Medetomidine-Midazolam-Buprenorphine Combinations and Reversibility by Atipamezole in Dogs
Väha-Vahe T. The clinical efficacy of medetomidine. Acta Vet Scand 1989,Suppl 85:151-154
Vainio O Introduction to the clinical pharmacology of medetomidine. Acta Vet Scand 1989;Suppl 85:85-88.
England GCW, Clarke KW. The use of medetomidine/fentanyl combinations in dogs Acta Vet Scand 1989,Suppl 85 179-186.
Bartram DH, Young LE, Diamond MJ, et al Effects of combinations of medetomidine/pethidine when used for sedation and pre-anaesthetic medication in dogs. J Small Anim Pract 1993;34.554-558
Sap R, Hellebrekers LJ The use of inedetomidine/femanyl for ovartohysterectomy in dogs J Vet Anaesth 1993,20 51
Bartram DH, Diamond MJ, Tute AS, et al. Use of medetomidine and butorphanol for sedation in dogs J Small Anim Pract 1994; 35:495-498.
Pypendop B, Verstegen J A comparison of the sedative and analgesic effects of buprenorphine in combination with acepromazine, midazolam or medetomidine in dogs. J Vet Anaesth 1994,21: 15-20.
Gross ME, Tranquilli WJ, Thurton JC, et al Hemodynamic effects of intravenous midazolam-xylazine-butorphanol in dogs. Vet Surg 1990;19 173-180.
Ilkiw JE. Other potentially useful new injectable anesthetic agents Opinions in small animal anesthesia. Vet Clin North Am Small Anim Pract 1992;22:281-289.
Raffe MR, Tranquilli WJ. Classifying commonly used analgesic agents. Vet Med 1989;84 687-690
Jalfe JH, Martin WR. Opioid analgesics and antagonists. In. Goodman Gilman A, Rail TW, Nies AS, et al, eds Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990,485-521.
Flecknell PA, Liles JH, Wootton R Reversal of fentanyl/ fluamsone neuroleptanalgesia in the rabbit using mixed agonist/antagonist opioids. Lab Anim 1989;23:147-155
Mitchell RWD, Smith G The control of acute postoperative pain. Br J Anaesth 1989,63:147-158
Tranquilli WJ, Fikes LL, Raffe MR Selecting the right analgesics: indications and dosage requirements. Vet Med 1989;84.692-697.
Viguier E. L'analgésie postopératoire. Le Point Vetérinaire 1993;25:383-395.
Savola J-M. Cardiovascular actions of medetomidine and their reversal by atipamezole. Acta Vet Scand 1989,Suppl 85:39-47
Lentner G. Statistical methods. In: Lentner G, ed. Geigy scientific tables, Introduction to stacistics, statistical tables and mathcmatical formulae. 8th ed. Basel, Switzerland: Ciba Geigy, 1982;199-203.
Benson GJ. Thurmon JC, Tranquilli WJ, et al. Cardiopulmonary effects of an intravenous infusion of guaifenesin, ketamine, and xylazine in dogs. Am J Vet Res 1985;46:1896-1898
Haskins SC, Patz JD, Farver TB, Xylazine and xylazine-ketamme in dogs. Am J Vet Res 1986;47 636-641
Seneyn D, Coppens P, Jones R, et al. Circulatory and respiratory effects of the combination medetomidine-ketamine in Beagles. J Vet Pharmacol Ther 1993;16:199-206.
Tranquilli WJ, Gross ME, Thurmon JC, et al. Evaluation of three midazolam-xylazine mixtures Preliminary trials in dogs. Vet Surg 1990,19:168-172.
Verstegen J, Petcho A. Medetomidine-butorphanol-midazolam for anaesthesia in dogs and its reversal by atipamezole Vet Rec 1993;132:353-357.
Hsu WH. Effects of atropine on xylazine-pentobarbital anesthesia in dogs: preliminary study. Am J Vet Res 1985;46.856-858.
Dunckle N, Morse S, Scarlett-Kranz J, et al. Cardiac performance in cats after administration of xylazine or xylazine and glycopyrrolate. echocardiographic evaluations Am J Vet Res 1986; 47.2212-2216.
Salonen JS Pharmacokinetics of medetomidine. Acta Vet Scand 1989,Suppl 85:49-54.
Hall LW, Clarke KW. Principles of sedation, analgesia and premedication. In Hall LW, Clarke KW, eds. Vcterinary anaesthesia. 9th ed. London: Batlliere Tindall, 1991,51-72.
Virtanen R Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand 1989:Suppl 85:29-37.
Muir WW. Piper FS Effect of Xylazine on indices of myocardial contractility in the dog Am J Vet Res 1977,38:931-934.
Jones DJ, Stehling LC, Zauder HL. Cardiovascular responses to diazepam and midazolam maleate in the dog Anesthesiology 1979; 51:430-434.
Gelman S, Reves JG, Harris D Circulatory responses to midazolam anesthesia: emphasis on canine splanchnic circulation. Anesth Analg 1983,62 135-139.
Adams P, Gelman S, Reves JG, et al. Midazolam pharmacodynainics and pharmacokinetics during acute hypovolemia Anesthesiology 1985;63:140-146.
Edwards NJ, Moise NS. Cardiovascular systern. In: Kirk RW, Bistncr SI, Ford RB. eds. Handbook of veterinary procedures and emergency treatment 5th ed. Philadelphia: WB Saunders Co, 1990,261.
Klide AM, Calderwood HW, Soma LR. Cardiopulmonary effects of xylazine in dogs Am J Vet Res 1975;36:931-935
Sedcherg J, Stanley TH, Reddy P, et al. Hemodynamic effects of butorphanol-oxygen anesthesia in dogs. Anesth Analg 1981;60: 715-719.
Vickery RG, Sheridan BC, Segal IS, et al. Anesthetic and hemodynainic effects of the stereoisomers of medetomidine. an α2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988;67:611-615.
Yukioka H, Fujimori M. Haeinodynamic effects of I.M opioids for analgesia during ventilator treatment after oesophagectomy. Can J Anaesth 1990;37:S115
Arnould JF, Pinaud M. Pharmacologie de la buprénorphine. Ann Fr Anesth Reanim 1991;10.559-564.
Okutani R, Kono K, Kinoshita O, et al. Variations in hemodynamic and stress hormonal responses in open heart surgery with buprenorphine/diazepam anesthesia. J Cardiothorac Anesth 1989;3.401-406.
Darovic GO Cardiovascular anatomy and physiology In: Darovic GO. ed. Hemodynamic monitoring Invasive and noninvasive clinical application Philadelphia WB Saunders Co, 1987.33-61.
Devete A, Schmeling WT. Kampine JP, et al. Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs. Anesthesiology 1994; 81:419-430.
Schmeling WT, Kampine JP, Roerig DL, et al. The effects of the stereoisomers of the α2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs Anesthestology 1991;75:499-511.
Flackc JW, Flacke WE, Bloor BC, et al. Hemodynamic effects of dexmedetomidine, an α2-adrenergic agonist, in autonomically denervated dogs. J Cardiovasc Pharmacol 1990;16 616-623
Muir WW. Fluid therapy during anesthesia and surgery In DiBartola SP, ed. Fluid therapy in small animal practice. Philadelphia: WB Saunders Co, 1992;486-506.
Kehlet H, Dahl JB The value of "multimodal" or "balanced analgesia" in postoperative pain treatment Anesth Analg 1993;77: 1048-1056